{
  "trial_id": "NCT03778294",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, histological confirmation of grade IV malignant glioma, estimated glomerular filtration rate (eGFR), ability to complete questionnaires, planned radiation treatment location, use of interfering drugs, pregnancy status, use of contraception, prior use of Avastin, ability to undergo MRI scans with contrast, ability to undergo 18F-DOPA-PET scan.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "ECOG Performance Status",
          "ECOG performance status"
        ],
        [
          "Path result/Molecular factors",
          "histological confirmation of grade IV malignant glioma"
        ],
        [
          "Use of alternating electrical therapy",
          "use of interfering drugs"
        ],
        [
          "Pregnancy status",
          "pregnancy status"
        ],
        [
          "Use of contraception",
          "use of contraception"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Corticosteroid therapy at study entry?",
        "Neurological Deficit",
        "History of seizure",
        "Extent of surgery",
        "MGMT",
        "Family history of brain tumor"
      ],
      "remaining_candidate_features": [
        "estimated glomerular filtration rate (eGFR)",
        "ability to complete questionnaires",
        "planned radiation treatment location",
        "prior use of Avastin",
        "ability to undergo MRI scans with contrast",
        "ability to undergo 18F-DOPA-PET scan."
      ]
    },
    "processed-gen-response": "Age, sex, race, ECOG performance status, histological confirmation of grade IV malignant glioma, estimated glomerular filtration rate (eGFR), ability to complete questionnaires, planned radiation treatment location, use of interfering drugs, pregnancy status, use of contraception, prior use of Avastin, ability to undergo MRI scans with contrast, ability to undergo 18F-DOPA-PET scan."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG performance status, eGFR, Tumor grade, Use of interfering drugs,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "ECOG Performance Status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Corticosteroid therapy at study entry?",
        "Path result/Molecular factors",
        "Neurological Deficit",
        "History of seizure",
        "Extent of surgery",
        "MGMT",
        "Family history of brain tumor",
        "Use of alternating electrical therapy"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "eGFR",
        "Tumor grade",
        "Use of interfering drugs"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG performance status, eGFR, Tumor grade, Use of interfering drugs"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Estimated Glomerular Filtration Rate (eGFR), Karnofsky Performance Status, Histological Grade, Tumor Location, Tumor Size.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Corticosteroid therapy at study entry?",
        "Path result/Molecular factors",
        "Neurological Deficit",
        "History of seizure",
        "Extent of surgery",
        "MGMT",
        "Family history of brain tumor",
        "Use of alternating electrical therapy"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Estimated Glomerular Filtration Rate (eGFR)",
        "Karnofsky Performance Status",
        "Histological Grade",
        "Tumor Location",
        "Tumor Size"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Estimated Glomerular Filtration Rate (eGFR), Karnofsky Performance Status, Histological Grade, Tumor Location, Tumor Size."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, ECOG performance status, estimated glomerular filtration rate (eGFR), histological diagnosis (glioblastoma or malignant glioma), planned radiation treatment site (Mayo Clinic Arizona or Mayo Clinic Rochester).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "ECOG Performance Status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Corticosteroid therapy at study entry?",
        "Path result/Molecular factors",
        "Neurological Deficit",
        "History of seizure",
        "Extent of surgery",
        "MGMT",
        "Family history of brain tumor",
        "Use of alternating electrical therapy"
      ],
      "remaining_candidate_features": [
        "sex",
        "estimated glomerular filtration rate (eGFR)",
        "histological diagnosis (glioblastoma or malignant glioma)",
        "planned radiation treatment site (Mayo Clinic Arizona or Mayo Clinic Rochester)"
      ]
    },
    "processed-gen-response": "Age, sex, ECOG performance status, estimated glomerular filtration rate (eGFR), histological diagnosis (glioblastoma or malignant glioma), planned radiation treatment site (Mayo Clinic Arizona or Mayo Clinic Rochester)."
  }
}